 The biopharma space bled along with the rest of the market and COVID-19 levered biotechs werent spared either.Biogen Inc NASDAQ: BIIB was in the news for all wrong reasons, as an employee conference held by the company in Boston from Feb. 24 to 27 was blamed for 77 of the 95 COVID-19 cases reported 